Clinical proteomics of myeloid leukemia

Myeloid leukemias are a heterogeneous group of diseases originating from bone marrow myeloid progenitor cells. Patients with myeloid leukemias can achieve long-term survival through targeted therapy, cure after intensive chemotherapy or short-term survival because of highly chemoresistant disease. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Hjelle, Sigrun M, Forthun, Rakel B, Haaland, Ingvild, Reikvam, Håkon, Sjøholt, Gry, Bruserud, Øystein, Gjertsen, Bjørn T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905101/
https://www.ncbi.nlm.nih.gov/pubmed/20587003
http://dx.doi.org/10.1186/gm162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905101/
https://www.ncbi.nlm.nih.gov/pubmed/20587003
http://dx.doi.org/10.1186/gm162

Ejemplares similares